Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 13/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 13/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 13/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 12/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 12/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | BRS3 | P32247 | 2/20 | 0.52 |
| ▸ | NOS2 | P35228 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 12/20 | 0.46 |
| ▸ | CYP2C8 | P10632 | 12/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 12/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8552373 | 0.91 | CYP2D6 (0.54) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL8503057 | 0.90 | CYP2C9 (0.53) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL10713337 | 0.90 | BRS3 (0.57) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL9025916 | 0.89 | CYP2D6 (0.52) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL9027024 | 0.85 | CYP2D6 (0.49) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL599742 | 0.85 | CYP2C9 (0.72) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL10918227 | 0.85 | CYP2D6 (0.58) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL8503277 | 0.85 | CYP2C9 (0.61) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL8500956 | 0.84 | CYP2D6 (0.47) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL8130650 | 0.83 | CYP2D6 (0.52) | CYP2D6CYP2C9CYP2C19CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998445-A | PEPTIC ULCERS | EISAI CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0268956-B2 | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same | EISAI CO LTD (JP) | 1998-04-15 | — | — | EP | disclosed |
| EP-0786461-A1 | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same | Eisai Co., Ltd. (JP) | 1997-07-30 | — | — | EP | disclosed |
| EP-0654471-A1 | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same | Eisai Co., Ltd. (JP) | 1995-05-24 | — | — | EP | disclosed |
| EP-0475456-A1 | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same | Eisai Co., Ltd. (JP) | 1992-03-18 | — | — | EP | disclosed |
| US-5045552-A | Pyridine derivatives having anti-ulcerative activity | EISAI CO., LTD. (JP) | 1991-09-03 | — | — | US | disclosed |
| EP-0268956-A2 | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same | Eisai Co., Ltd. (JP) | 1988-06-01 | — | — | EP | disclosed |